Risk factors, demographics and clinical profile of Acanthamoeba keratitis in Melbourne: an 18-year retrospective study

Purpose To assess incidence, risk factors, presentation and final visual outcome of patients with Acanthamoebakeratitis (AK) treated at the Royal Victorian Eye and Ear Hospital (RVEEH), Melbourne, Australia, over an 18-year period. Methods A retrospective review of all cases of AK managed at RVEEH between January 1998 and May 2016 was performed. Data collected included age, gender, affected eye, signs and symptoms, time between symptoms and diagnosis, risk factors, presenting and final visual acuity (VA), investigations, medical treatment, surgical interventions and length of follow-up. Results A total of 36 eyes affected by AK in 34 patients were identified. There were 26 cases diagnosed early (<30 days) and 10 were diagnosed late (≥30 days). There were 31 (86.1%) cases associated with contact lens (CL). Signs associated with early AK included epithelial infiltrates, while signs of late AK included uveitis, ring infiltrate, endothelial plaque and corneal thinning (p<0.05). Surgical treatment was required in seven cases (19.4%). There were 29 (80.6%) cases that reported improved VA. Median best corrected final VA was worse in patients with late diagnosis (logarithm of minimal angle of resolution (logMAR) 0.5, IQR: 0.2–0.8), compared with patients with early diagnosis (logMAR 0.0, IQR: 0.0–0.3; p=0.01). Late diagnosis was associated with a prolonged disease period. Conclusion AK was an uncommon cause of severe keratitis and was associated commonly with CL. Patients with late diagnosis had worse presenting and final VAs as well as a prolonged disease period, indicating need for early recognition and management.

[1]  R. Jayaswal,et al.  Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes , 2016, Cornea.

[2]  Lamprini Papaioannou,et al.  Corneal Collagen Cross-Linking for Infectious Keratitis: A Systematic Review and Meta-Analysis , 2016, Cornea.

[3]  V. Jhanji,et al.  Acanthamoeba keratitis: 10-year study at a tertiary eye care center in Hong Kong. , 2015, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[4]  J. Lorenzo-Morales,et al.  An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment , 2015, Parasite.

[5]  Donald L. Budenz,et al.  Risk Factors for Tube Shunt Exposure: A Matched Case-Control Study , 2013, Journal of ophthalmology.

[6]  W. Mathers,et al.  Acanthamoeba Keratitis: A 12-Year Experience Covering a Wide Spectrum of Presentations, Diagnoses, and Outcomes , 2013, Journal of ophthalmology.

[7]  S. Swamynathan Ocular Surface Development and Gene Expression , 2013, Journal of ophthalmology.

[8]  M. Srinivasan,et al.  Acanthamoeba Keratitis in South India: A Longitudinal Analysis of Epidemics , 2012, Ophthalmic epidemiology.

[9]  J. Shimazaki,et al.  Visual outcome in Japanese patients with Acanthamoeba keratitis , 2012, Eye.

[10]  E. Cohen,et al.  Clinical Outcomes and Prognostic Factors Associated With Acanthamoeba Keratitis , 2011, Cornea.

[11]  K. Colby,et al.  The Clinical Experience of Acanthamoeba Keratitis at a Tertiary Care Eye Hospital , 2010, Cornea.

[12]  D. Meisler,et al.  Clinical Experience With Acanthamoeba Keratitis at the Cole Eye Institute, 1999–2008 , 2010, Cornea.

[13]  J. Lai,et al.  Retrospective case series on the long-term visual and intraocular pressure outcomes of phacomorphic glaucoma , 2010, Eye.

[14]  D. Patel,et al.  Resurgence of Acanthamoeba keratitis in Auckland, New Zealand: a 7‐year review of presentation and outcomes , 2010, Clinical & experimental ophthalmology.

[15]  J. Mehta,et al.  Acanthamoeba keratitis associated with contact lens wear in Singapore. , 2009, American journal of ophthalmology.

[16]  D. Low,et al.  Laboratory Diagnosis of Amoebic Keratitis: Comparison of Four Diagnostic Methods for Different Types of Clinical Specimens , 2009, Journal of Clinical Microbiology.

[17]  P. Beckingsale,et al.  Acanthamoeba keratitis cluster: an increase in Acanthamoeba keratitis in Australia , 2009, Clinical & experimental ophthalmology.

[18]  S. Kilvington,et al.  Acanthamoeba keratitis: diagnosis and treatment update 2009. , 2009, American journal of ophthalmology.

[19]  J. Sugar,et al.  Prognostic factors affecting visual outcome in Acanthamoeba keratitis. , 2008, Ophthalmology.

[20]  J. Sugar,et al.  The Relative Value of Confocal Microscopy and Superficial Corneal Scrapings in the Diagnosis of Acanthamoeba Keratitis , 2008, Cornea.

[21]  C. Bunce,et al.  Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. , 2008, American journal of ophthalmology.

[22]  E. Cohen,et al.  Acanthamoeba Keratitis: A Parasite on the Rise , 2007, Cornea.

[23]  M. Kainer,et al.  Acanthamoeba keratitis multiple states, 2005-2007. , 2007, MMWR. Morbidity and mortality weekly report.

[24]  G. Sutton,et al.  Six‐year review of Acanthamoeba keratitis in New South Wales, Australia: 1997–2002 , 2005, Clinical & experimental ophthalmology.

[25]  D. Frazer,et al.  Acanthamoeba keratitis: the role of domestic tap water contamination in the United Kingdom. , 2004, Investigative ophthalmology & visual science.

[26]  I. Claerhout,et al.  Delay in diagnosis and outcome of Acanthamoeba keratitis , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[27]  Colette,et al.  CLINICAL SCIENCE. , 1938, British medical journal.